Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Ubiquitin ligase Atrogin1/Muscle Atrophy F-box (MAFbx) up-regulation is required for skeletal muscle atrophy but substrates and function during the atrophic process are poorly known. The transcription factor MyoD controls myogenic stem cell function and differentiation, and seems necessary to maintain the differentiated phenotype of adult fast skeletal muscle fibres. We previously showed that MAFbx mediates MyoD proteolysis in vitro. Here we present evidence that MAFbx targets MyoD for degradation in several models of skeletal muscle atrophy. In cultured myotubes undergoing atrophy, MAFbx expression increases, leading to a cytoplasmic-nuclear shuttling of MAFbx and a selective suppression of MyoD. Conversely, transfection of myotubes with sh-RNA-mediated MAFbx gene silencing (shRNAi) inhibited MyoD proteolysis linked to atrophy. Furthermore, overexpression of a mutant MyoDK133R lacking MAFbx-mediated ubiquitination prevents atrophy of mouse primary myotubes and skeletal muscle fibres in vivo. Regarding the complex role of MyoD in adult skeletal muscle plasticity and homeostasis, its rapid suppression by MAFbx seems to be a major event leading to skeletal muscle wasting. Our results point out MyoD as the second MAFbx skeletal muscle target by which powerful therapies could be developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521 · cited 1×
“MAFbx [2,3] that associates with Skp1, Cul1 and Roc1 to form an SCF-type ubiquitin ligase [4,5].”
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012 · cited 2×
“food deprivation leads to rapid muscle wasting and increases MAFbx mRNA expression in vivo and in C2C12 cultures [6,7] we”
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
MyoD is required for myogenic stem cell function in adult skeletal muscle
Megeney, L. A., Kablar, B., Garrett, K., Anderson, J. E., & Rudnicki, M. A. (1996) · Genes & Development · doi:10.1101/gad.10.10.1173 · Cited by 724 · cited 2×
“Although MyoD is clearly required for efficient muscle repair [12] the loss of myoD function was shown to lead to failure to maintain”
What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?
Jagoe, R. T., & Goldberg, A. L. (2001) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200105000-00003 · Cited by 399 · cited 1×
“Skeletal muscle atrophy is characterized by an increase in proteolysis, particularly via the ATP-dependent ubiquitin-proteasome pathway”
BackgroundTumor necrosis factor-alpha inhibits myogenic differentiation through myod protein destabilization
Langen, R. C. J., van der Velden, J. L. J., Schols, A. M. W. J., Kelders, M. C. J. M., Wouters, E. F. M., & Janssen‐Heininger, Y. M. W. (2004) · The FASEB Journal · doi:10.1096/fj.03-0251com · Cited by 319 · cited 1×
“Depending on the atrophic signaling pathway, MyoD expression seems to be inhibited both at the RNA and protein levels suggesting that in vivo, MyoD down-regulation is crucial for muscle loss [8,21,29].”
Cited by
Ubiquitination in disease pathogenesis and treatment
Popovic, D., Vucic, D., & Dikic, I. (2014) · Nature Medicine · doi:10.1038/nm.3739 · Cited by 1,401
Signaling pathways controlling skeletal muscle mass
Egerman, M. A., & Glass, D. J. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.857291 · Cited by 555
The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy
Foletta, V. C., White, L. J., Larsen, A. E., Léger, B., & Russell, A. P. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0919-9 · Cited by 357
FoxO transcription factors: their roles in the maintenance of skeletal muscle homeostasis
Sanchez, A. M. J., Candau, R. B., & Bernardi, H. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1513-z · Cited by 335
Bindels, L. B., Beck, R., Schakman, O., Martin, J. C., De Backer, F., Sohet, F. M., Dewulf, E. M., Pachikian, B. D., Neyrinck, A. M., Thissen, J.-P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037971 · Cited by 278
The FSHD Atrophic Myotube Phenotype Is Caused by DUX4 Expression
Vanderplanck, C., Ansseau, E., Charron, S., Stricwant, N., Tassin, A., Laoudj-Chenivesse, D., Wilton, S. D., Coppée, F., & Belayew, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026820 · Cited by 208
“They encode E3 ubiquitin ligases that bind to myofibril proteins, cause their ubiquitination and subsequent degradation via the proteasome [25].”
BackgroundThe ubiquitin proteasome system in neuropathology
Lehman, N. L. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0560-x · Cited by 207
“MAFbx gene silencing by RNA interference inhibits MyoD proteolysis and expression of a stabilized K133R MyoD mutant not recognized by SCF-MAFbx prevents atrophy of mouse skeletal muscle fibers in model systems [72].”
BackgroundAnabolic and catabolic pathways regulating skeletal muscle mass
McCarthy, J. J., & Esser, K. A. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833781b5 · Cited by 148
The Transcription Factor ATF4 Promotes Skeletal Myofiber Atrophy during Fasting
Ebert, S. M., Monteys, A. M., Fox, D. K., Bongers, K. S., Shields, B. E., Malmberg, S. E., Davidson, B. L., Suneja, M., & Adams, C. M. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0345 · Cited by 130
Goodman, C. A., Dietz, J. M., Jacobs, B. L., McNally, R. M., You, J.-S., & Hornberger, T. A. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.04.047 · Cited by 121
Mueller, T. C., Bachmann, J., Prokopchuk, O., Friess, H., & Martignoni, M. E. (2016) · BMC Cancer · doi:10.1186/s12885-016-2121-8 · Cited by 95
“The transcription factor MyoD is an essential regulator of myogenesis and myoblast differentiation, and is crucial for regeneration of muscle tissue from satellite cells [14, 156, 157].”
BackgroundCisternas, F., Morales, M. G., Meneses, C., Simon, F., Brandan, E., Abrigo, J., Vazquez, Y., & Cabello-Verrugio, C. (2015) · Clinical Science · doi:10.1042/cs20140215 · Cited by 83
Kob, R., Fellner, C., Bertsch, T., Wittmann, A., Mishura, D., Sieber, C. C., Fischer, B. E., Stroszczynski, C., & Bollheimer, C. L. (2015) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12019 · Cited by 48
“While MuRF1 primarily acts on the proteasomal decay of muscular structure proteins, MAFbx regulates protein transcription by degrading MyoD and eIF3-f.(42,43) In contrast to a study with overweight Wistar rats, we were not able to detect a significant elevation in MuRF1 protein content because of the HFD.”
BackgroundMelanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease
Cheung, W. W., & Mak, R. H. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00341.2012 · Cited by 47
Small molecule adiponectin receptor agonist GTDF protects against skeletal muscle atrophy
Singh, A. K., Shree, S., Chattopadhyay, S., Kumar, S., Gurjar, A., Kushwaha, S., Kumar, H., Trivedi, A. K., Chattopadhyay, N., Maurya, R., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.09.013 · Cited by 42
“LT also robustly enhanced mRNA and protein levels of MuRF1 and Atrogin-1, 338 and caused a severe reduction in MyoD protein level (Fig.”
BackgroundInfluentialLee, H., Lee, S.-J., Bae, G.-U., Baek, N.-I., & Ryu, J.-H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122748 · Cited by 26
“These include muscle RING finger 1 (MuRF1) [41], muscle atrophy F-box (MAFbx)/atrogin-1 [42], and ubiquitin protein ligase E3 component N-recognin 2 (UBR2) [43].”
Background
Metadata
- Authors
- Lagirand-Cantaloube, J., Cornille, K., Csibi, A., Batonnet-Pichon, S., Leibovitch, M. P., & Leibovitch, S. A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-03-25
- Volume
- 4
- Issue
- 3
- Pages
- e4973
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1974706622
- Cited by
- 202
- References
- 6
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.